SUMMARY Investigations into the possibility that X (an antigen consistently present in aspirated odontogenic keratocysts, but not in most fluids from other cyst types), represented a keratinocyte component failed to identify the antigen as a keratin, involucrin, or one of the blood group substances. Antigen X was detected in human mixed and parotid saliva and in colostrum, as well as in a commercially obtained preparation of colostral IgA. The antigen was similar biochemically to both secretory component and lactoferrin but proved to be identical antigenically with lactoferrin.
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The origin of lactoferrin in keratocyst fluids remains uncertain, though the lining epithelium seems a more likely source than does the very variable, and often negligible, inflammatory infiltrate found in these lesions.
Of the cysts that occur in the jaws, only the odontogenic keratocyst shows a significant tendency to recur after surgical removal.1 Since a proportion of coventionally biopsied cystic tissue cannot be diagnosed histologically, usually because of excessive inflammation, other methods of achieving accurate preoperative diagnosis have been investigated. Toller examined the total soluble protein concentrations in the fluid that can usually be aspirated from these cysts and showed that keratocyst fluids contained a significantly lower concentration of protein.2 This characteristic, along with the presence of keratinised squames in the fluid,3 is held to be consistent with a diagnosis of odontogenic keratocyst.
Nevertheless, as some cysts are often heavily inflamed or infected and fluid aspirates commonly become contaminated with blood during collection, the total protein concentration tends to be raised. Clearly, then, protein concentration alone cannot be relied on for diagnosis, and recognition of more definitive markers in cyst fluids would be advantageous. We recently described a study in which a range of cyst fluids was analysed immunochemically in an attempt to identify markers specific to odontogenic keratocysts.4 s By raising an antiserum against pooled keratocyst fluids and screening individual cyst fluids against this serum, an antigen, designated X, was identified that seemed to be confined to keratocyst fluids. The presence and detection of X was independent of the concentration of total soluble Accepted for publication 26 March 1987 protein and did not seem to be related to the presence or degree of inflammation.
Antigen X was not detected in serum, and some evidence suggested that it might originate from the epithelium lining the cyst cavity. Antigen X was shown to be distinct from most human keratins,5 and so the present study investigated a variety of other substances associated with epithelium as potential candidates for identification with X. These included involucrin,6 blood group substances,7 and the secretory substances lactoferrin8 and secretory component.9 We report here evidence to indicate that antigen X can be identified as lactoferrin.
Material and methods

CYST FLUIDS
A variety of fluids that had been aspirated from cystic lesions diagnosed histologically as odontogenic keratocysts were used as the source of antigen X. These keratocyst fluids had been collected over a period of six years and stored at -20°C. The total soluble protein concentration of the fluids ranged from 1-8-10 g/100 ml and prior to use fluids were centrifuged at 11600 g for 10 minutes in an MSE microcentaur centrifuge.
SALIVA AND COLOSTRUM
Human whole mixed saliva (from the authors) was stimulated by chewing parafilm (American Can Co.) and cleared by centrifugation at 11 600 g for 10 minutes in an MSE microcentaur centrifuge. Parotid Evidence for the presence of lactoferrin in odontogenic keratocyst fluids saliva was collected from the authors using a CarlsonCrittenden cup while stimulating the tongue with lemon oil.
Pooled human colostrum collected in the period immediately after birth was obtained from the University department of obstetrics and gynaecology, Sheffield.
ANTISERA
Antibodies to a partially purified preparation of antigen X and to human whole mixed saliva were raised in New Zealand white rabbits by three consecutive injections at three weekly intervals, using aluminium hydroxide as adjuvant (Alu Gel S, Serva, Heidelberg Antigen X began to emerge from the column shortly after the void volume (fraction 6), peaked in fraction 17, and persisted until fraction 22. The bulk of the serum related components began to elute in fraction 12; accordingly, fractions 6-11 were pooled and used to raise an antiserum against antigen X.5
The anti-X serum obtained was then coupled to a silica matrix activated with glutaraldehyde (BCL, London) and packed into a column (10 x 1 cm). An antihuman serum immunoaffinity column was also prepared by coupling commercial antihuman serum immunoglobulin to the same affinity matrix. All subsequent preparations of antigen X were produced by initial passage of a mixture of keratocyst fluids through the anti-X immunoaffinity column followed by washing and desorption with 10 mM hydrochloric acid. This "enriched" X preparation contained some contaminant serum components. After dialysis against 0-05M phosphate buffer the serum contaminants were removed by passage through the antihuman serum affinity column. The resultant partially purified antigen X material was almost totally devoid of most contaminant material, as judged by probing Western blots with antihuman serum and antikeratin antibodies.
SODIUM DODECYL SULPHATE-POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE) AND WESTERN BLOTTING
Samples were electrophoresed in the presence of SDS on 9% polyacrylamide gels according to the method described by Russell,'2 but with the exception that P-mercaptoethanol was usually omitted from the sample buffer.
Electrophoretic transfer of proteins on to nitrocellulose (Schleicher and Schull, Dassel, West Germany) following SDS-PAGE-that is, Western blotting-was performed essentially according to the method of Burnette,"3 but with the modifications reported by Douglas and Russell. In some experiments keratocyst fluids were examined by running in "tandem" with human lactoferrin in the CIE system. IMMUNOAFFINITY CHROMATOGRAPHY OF SECRETORY IgA (S-IgA) A commercial preparation of colostral S-IgA (Sigma) was passed down an immunoaffinity column constructed from anti-a chain antibodies (Boehringer, Mannheim) and antisecretory component immunoglobulin (Dako) immobilised on a matrix activated with glutaraldehyde (BCL, London). Bound constituents were desorbed using 10mM hydrochloric acid and, after dialysis, both the bound and non-bound components were examined by western blotting. In Western blots none of the antisera used recognised antigen X (data not shown). Western blotting. The antigen was readily identified in all these secretions and, although not measured, the amount of X present in each was considerable, particularly in colostrum as the sample had to be diluted 1/300 to avoid overloading of the gel. Some variation in the band patterns of antigen X was observed between the various samples but the reason for this is ntt'-x Ant -SC Ant'--.s5>--; ' r- Evidence for the presence of lactoferrin in odontogenic keratocyst fluids not known at present.
Bearing the above results in mind, along with the previously reported biochemical characteristics of antigen X5 and the fact that it is not of serum origin or of the keratin family, we speculated at this stage that X might be secretory component.
IDENTITY OF X: SECRETORY COMPONENT
Using the method of Western blotting, antibody to antigen X did not recognise secretory component isolated from human colostrum (fig 2) , nor did antibody to free secretory component recognise antigen X. Anti-X antibody did, however, recognise a molecule running to the same position as secretory component when a preparation of colostral secretory IgA was run in dissociating conditions and probed on Western blots (fig 2) . At no time did anti-a chain serum recognise antigen X and anti-X serum did not recognise IgA.
0D
Anti-OK ( S-IgA PURIFICATION BY IMMUNOAFFINITY CHROMATOGRAPHY To investigate further the apparent anomolous observation that a component in the S-IgA preparation was similar antigenically to X, attempts were made to separate any unbound impurities from either S-IgA or any free secretory component that may have been present. An affinity column, constructed from anti oa-chain and antisecretory component immunoglobulins, was used, and the material passing straight through the column, and that bound and subsequently desorbed, were assayed by Western blotting. No material recognisable by anti-X antibody passed straight through the affinity column. All the "anti-X-positive" material remained bound to the column; after desorption with 10mM hydrochloric acid this component ran to a position corresponding to that of secretory component on SDS-PAGE. Since anti-X antibodies stained PMNL strongly by the immunoperoxidase method we investigated the possibility that X might be lactoferrin, a substance present in both PMNL and body secretions but not in serum. This thesis was initially tested using "tandem" crossed immunoelectrophoresis in which a keratocyst fluid was run alongside a sample of lactoferrin (100 jg/ml). A large double peak was produced ( fig  3b) , both "humps" of the peak being contiguous, indicating antigenic identity; for comparison, fig 3a  shows Evidence for the presence of lactoferrin in odontogenic keratocyst fluids tinising epithelia, although we recently reported that X was distinct from most cornification keratins.5 Another substance that is exclusively associated with keratinocytes and was, therefore, thought worthy of consideration, is involucrin, a cytoplasmic protein that has a role, along with several other membrane associated proteins, in the formation of an insoluble submembranous envelope during differentiation. 6 19 Involucrin was originally reported as having an apparent molecular weight of 90 000,6 but more recently it has been shown to behave anomolously in PAGE depending on the polyacrylamide concentration used.'9 Accordingly, we considered that involucrin might well behave in a manner similar to that of antigen X, which resolves as two bands with molecular weights of 81 000 and 89 000 in the SDS-PAGE system used here. By Western blotting, however, X was shown to be antigenically distinct from involucrin. Thus although no specific association between antigen X and keratinocyte components could be found, it still seemed unlikely that X was a general epithelial component, although at this stage it was not known if the antigen was present in other lesions, body sites, or fluids. We therefore assayed certain secretions for the presence of antigen X and found easily detectable quantities in mixed and parotid salivas, and in colostrum; these findings led us to consider which components might be common to both epithelial secretions.
Of the various possibilities, two substances in particular seemed to have similar biochemical properties to antigen X-namely, secretory component and lactoferrin. Blood group antigens were also considered at this juncture because of their known association with epithelial membranes, but these proved to be unrelated to X antigenically.
Secretory component is an epithelial product responsible for the transport of dimeric IgA across the epithelial barrier9 and reportedly has molecular weights in the range 78 000 to 90 000. It resolves as a double band on SDS-PAGE20 and has a major antigenic epitope that is sensitive to reduction with P-mercaptoethanol.2' Lactoferrin is an iron binding protein that is both actively released into external secretions22 and is also present in the azurophilic granules of polymorphonuclear leucocytes (PMNL)23; its reported molecular weight is in the range 76 80085000.24 25 Although the molecule comprises two iron binding sites stabilised by disulphide bonds,26 we are not aware of any reports indicating that the major antigenic epitope of the molecule spans these sites, thus making it sensitive to reduction with 1-mercaptoethanol. In this regard it seemed that antigen X showed a greater similarity to secretory component and, therefore, their association was investigated first.
Western blot analysis of free secretory component showed that it was not recognised by anti-X antibody, nor did antibody directed against the free or bound forms of secretory component recognise antigen X. Interestingly, however, anti-X serum did recognise a component in a commercial preparation of S-IgA which migrated to the same position as secretory component in SDS-PAGE. This "X-positive" material was not a fragment of IgA as it was not recognised by anti-ax chain antibody and anti-X serum did not recognise IgA. Could the "X-positive" material be an unusual form of secretory component? Although reducing conditions are normally considered to be necessary to cleave secretory component from S-IgA,27 some did seem to be released by boiling in SDS in the absence of 3-mercaptoethanol, or possibly some free secretory component was also present in the S-IgA preparation we used here. An alternative interpretation for the presence of "X-positive" material in the S-IgA preparation is that it merely represents an unrelated contaminant that fortuitously has a molecular weight similar to secretory component.
To try to resolve these two possible explanations we first attempted to separate any contaminants from any free secretory component that might have been present and from the S-IgA, by chromatography on an affinity column constructed from anti-a chain and anti-secretory component immunoglobulins. The material recognised by anti-X serum bound to the column and subsequently was desorbed along with S-IgA, again suggesting that it might be related to secretory component.
Investigations into the biological activity of secretory component and antigen X, however, showed that like secretory component'6 X was capable of binding to dog dimeric IgA; in contrast to secretory component, however, antigen X also bound to bovine serum albumin which had been included as a control. Such non-specific binding to proteins other than dimeric IgA or pentameric IgM has not been reported for secretory component,'6 but the other candidate substance under consideration for identity with Xnamely lactoferrin-is known to interact with a variety of proteins. 28 Although some of the data discussed so far tend to suggest that antigen X is an unusual form of secretory component, there are important differences between them, not least being the lack of recognition of X by antisecretory component sera. Furthermore, should X be a variant form of secretory component, one might expect that it would share at least some antigenic epitopes with the native form of the molecule. Therefore the 'X-positive' material in our S-IgA preparation, which comigrates with secretory component on SDS-PAGE, is more likely to be an impurity than a variant secretory component, and the fact that this 920 Douglas, Craig material was retained on the anti-a chain immunoaffinity column could simply be explained on the basis of a strong, non-specific interaction between X and IgA. Indeed, information obtained subsequently from the manufacturers of the S-IgA preparation used here has indicated that lactoferrin was present as an impurity to a level of 0.5%.
The weight of evidence would now suggest that antigen X is lactoferrin; this conclusion is supported by positive cytoplasmic staining of PMNL in tissue sections with anti-X antibody, specific interaction between lactoferrin, and anti-X antibody, in CIE and Western blots, and by anti-lactoferrin serum recognising antigen X. Chance antigenic cross reactivity between the two molecules, however, cannot be totally ruled out at this stage, even though the behaviour of X and lactoferrin seem to be identical on SDS-PAGE.
Finally, the question arises as to how lactoferrin consistently accumulates in keratocyst fluids? Certainly, its presence would seem to be unrelated solely to inflammation as keratocysts, which have a developmental pathogenesis, are in most instances virtually uninflamed histologically at the time of diagnosis. In contrast, very few fluids from radicular cysts have been found to contain antigen X, yet inflammation is an essential prerequisite in their pathogenesis. It is tempting to speculate, therefore, that in keratocyst fluids X originates from the epithelial lining rather than from infiltrating PMNL. Though lactoferrin is well characterised as a product of secretory epithelia-for example, breast, sweat gland, salivary gland-and in certain lining epithelia-gastric mucous neck cells and duodenum-a recent study failed to detect it in keratinising epithelium of skin.8 Nevertheless, both the major and minor salivary glands and the odontogenic epithelial remnants from which keratocysts are thought to arise share a common origin embryologically in the ectoderm that lines the primitive oral cavity; this suggests that keratocyst lining epithelium might exhibit a capacity for lactoferrin production. To date, however, our limited attempts at immunoperoxidase localisation of lactoferrin in formalin fixed keratocyst linings have been disappointing, though work in progress using different fixation schedules may help to resolve this problem.
An alternative explanation, however, for the presence of a relatively large amount of lactoferrin in keratocyst fluids might be related to the nature of the cyst lining, rather than to specific products of that lining. In view of the postulation that keratocyst linings are relatively impermeable to proteins29 it is possible that the PMNL that do infiltrate the cyst lining act as the source of lactoferrin in the cyst fluid. The lactoferrin concentration might, then, gradually increase with time, because it is unable to diffuse away into the surrounding tissues. Further work is required to resolve these speculations. 
